Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,31604114,circulating half-life,"This study executed the human albumin-fusion technology, a simple and flexible approach to extend the serum circulating half-life of cIFN, because human serum albumin (HSA) has long circulating half-life (19 days) and very minute immunological activities.",Production of potent long-lasting consensus interferon using albumin fusion technology in Pichia pastoris expression system. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31604114/),d,19,76772,DB00069,Interferon alfacon-1
,18985796,apparent clearance (dose(sc)/AUC),The apparent clearance (dose(sc)/AUC) decreased from 150 mL/h/kg for CIFN to 19.0-45.5 mL/h/kg for PEG-CIFNs.,Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys. ,CLpo-Q27,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18985796/),[ml] / [h·kg],150,117987,DB00069,Interferon alfacon-1
,18985796,apparent clearance (dose(sc)/AUC),The apparent clearance (dose(sc)/AUC) decreased from 150 mL/h/kg for CIFN to 19.0-45.5 mL/h/kg for PEG-CIFNs.,Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys. ,CLpo-Q27,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18985796/),[ml] / [h·kg],19.0-45.5,117988,DB00069,Interferon alfacon-1
